* CareDx Inc reported quarterly adjusted earnings of 14 cents per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of -18 cents. The mean expectation of nine analysts for the quarter was for earnings of one cent per share. Wall Street expected results to range from -2 cents to 6 cents per share.
* Revenue rose 23.4% to $82.88 million from a year ago; analysts expected $80.53 million.
* CareDx Inc's reported EPS for the quarter was a loss of 14 cents.
* The company reported a quarterly loss of $7.41 million.
* CareDx Inc shares had fallen by 26.6% this quarter and gained 91.1% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by about 498.8% in the last three months.
* In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the biotechnology & medical research peer group is also "buy"
Wall Street's median 12-month price target for CareDx Inc is 35.00 This summary was machine generated from LSEG data November 5 at 08:00 a.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.01 0.14 Beat
Jun. 30 2024 -0.14 0.25 Beat
Mar. 31 2024 -0.21 -0.03 Beat
Dec. 31 2023 -0.27 -0.17 Beat
Comments